Serum IL-1[beta] and IL-17 levels in patients with COPD: associations with clinical parameters

COPD is a chronic airway inflammatory disease characterized mainly by neutrophil airway infiltrations. Interleukin (IL)-1[beta] and IL-17 are the key mediators of neutrophilic airway inflammation in COPD. This study was undertaken to evaluate the serum IL-1[beta] and IL-17 levels and associations between these two key mediators with clinical parameters in COPD patients. Serum samples were collected from 60 COPD subjects during the acute exacerbation of COPD, 60 subjects with stable COPD and 40 healthy control subjects. Commercial enzyme-linked immunosorbent assay kits were used to measure the serum IL-1 [beta] and IL-17 concentrations. The association between serum IL-1 [beta] and IL-17 with [FEV.sub.1]% predicted, C-reactive protein, neutrophil percentage and smoking status (pack-years) was assessed in the COPD patients. We found that serum IL-1 [beta] and IL-17 levels in acute exacerbation of COPD subjects were significantly higher than that in stable COPD or control subjects and were positively correlated to serum C-reactive protein levels, neutrophil % and smoking status (pack-years) but negatively correlated with [FEV.sub.1]% predicted in COPD patients. More importantly, serum IL-1 [beta] levels were markedly positively associated with serum IL-17 levels in patients with COPD (P=0.741, P